We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tris Pharma Draws Form 483 Over Quality Lapses
FDA investigators observed multiple quality lapses during an inspection at Tris Pharma’s Monmouth Junction, New Jersey facility and issued a 19-page inspection report.
